We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$5.61B
AUM Growth
+$1.61M
Cap. Flow
-$357M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.1%
Holding
464
New
65
Increased
116
Reduced
184
Closed
45

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$58.3M
2
RDN icon
Radian Group
RDN
+$50.8M
3
PHM icon
Pultegroup
PHM
+$42M
4
CAVM
Cavium, Inc.
CAVM
+$39.7M
5
ADBE icon
Adobe
ADBE
+$34M

Top Sells

Rank Stock Value
1
MAN icon
ManpowerGroup
MAN
+$76.7M
2
SSNC icon
SS&C Technologies
SSNC
+$71.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$57.6M
4
JCP
J.C. Penney Company, Inc.
JCP
+$56.8M
5
CRM icon
Salesforce
CRM
+$53.2M

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Financials 17.22%
3 Consumer Discretionary 15.09%
4 Healthcare 11.48%
5 Industrials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLM icon
226
SLM Corp
SLM
$5.15B
$6.04M 0.11%
+808,225
New +$5.81M
NVRI icon
227
Enviri
NVRI
$620M
$6.03M 0.11%
607,630
-39,585
-6% -$377K
MBLY
228
DELISTED
Mobileye N.V.
MBLY
$5.94M 0.11%
+139,430
New +$6.45M
TFC icon
229
Truist Financial
TFC
$64B
$5.82M 0.1%
154,158
+8,462
+6% +$315K
GM icon
230
General Motors
GM
$76.8B
$5.81M 0.1%
182,800
-169,164
-48% -$5.28M
XEL icon
231
Xcel Energy
XEL
$48.8B
$5.72M 0.1%
138,965
+9,515
+7% +$407K
HP icon
232
Helmerich & Payne
HP
$3.71B
$5.67M 0.1%
84,196
+27,654
+49% +$1.74M
GMED icon
233
Globus Medical
GMED
$11.2B
$5.65M 0.1%
250,402
+113,507
+83% +$2.67M
SCHW
234
Charles Schwab
SCHW
$187B
$5.61M 0.1%
177,750
+25,000
+16% +$733K
FDX icon
235
FedEx
FDX
$75.4B
$5.59M 0.1%
32,000
+4,000
+14% +$655K
RDS.A
236
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$5.55M 0.1%
114,725
+3,768
+3% +$184K
COST icon
237
Costco
COST
$420B
$5.5M 0.1%
36,080
+2,000
+6% +$323K
CELG
238
DELISTED
Celgene Corp
CELG
$5.49M 0.1%
52,510
+7,500
+17% +$812K
BRCD
239
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$5.47M 0.1%
592,206
+136,050
+30% +$1.27M
MXIM
240
DELISTED
Maxim Integrated Products
MXIM
$5.46M 0.1%
136,643
+7,835
+6% +$309K
BRKR icon
241
Bruker
BRKR
$8.14B
$5.42M 0.1%
239,405
+146,635
+158% +$3.36M
BHC icon
242
Bausch Health
BHC
$2.34B
$5.36M 0.1%
+218,430
New +$5.65M
ROG icon
243
Rogers Corp
ROG
$2.4B
$5.33M 0.1%
+87,245
New +$5.3M
AXP icon
244
American Express
AXP
$230B
$5.25M 0.09%
82,000
– –
ORCL icon
245
Oracle
ORCL
$423B
$5.25M 0.09%
133,700
– –
OXY icon
246
Occidental Petroleum
OXY
$55.9B
$5.25M 0.09%
72,000
– –
WMGI
247
DELISTED
Wright Medical Group Inc
WMGI
$5.2M 0.09%
212,125
+56,850
+37% +$1.31M
EVRI
248
DELISTED
Everi Holdings
EVRI
$5.18M 0.09%
2,098,215
+337,660
+19% +$671K
KATE
249
DELISTED
Kate Spade & Company
KATE
$5.15M 0.09%
300,425
-39,425
-12% -$764K
SONC
250
DELISTED
Sonic Corp
SONC
$5.14M 0.09%
196,436
-384,320
-66% -$10.6M
8 9
10
11 12

Similar funds

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Chartwell Investment Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Chartwell Investment Partners held 464 positions worth $5.61B, up 0.03% from $5.61B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Chartwell Investment Partners withdrew a net $357M in Q3 2016, closing 45 positions and reducing 184 holdings. Its most notable exit was ManpowerGroup, an estimated $76.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Chartwell Investment Partners opened a new position in BioMarin Pharmaceuticals worth $57.3M.

  • Chartwell Investment Partners's largest Q3 2016 buy was BioMarin Pharmaceuticals: 619,625 shares worth $57.3M.
  • Chartwell Investment Partners added most to Pultegroup in Q3 2016, an estimated $42M increase.
  • Chartwell Investment Partners's biggest Q3 2016 reduction was SS&C Technologies, cutting an estimated $71.2M.
  • Chartwell Investment Partners fully exited ManpowerGroup in Q3 2016, selling an estimated $76.7M.
  • Chartwell Investment Partners's ten largest holdings make up 16% of its $5.61B portfolio in Q3 2016.
  • Chartwell Investment Partners opened 65 new positions and closed 45 in Q3 2016.
  • Chartwell Investment Partners's portfolio value rose 0.03% quarter-over-quarter to $5.61B.

Based on Chartwell Investment Partners's 13F filing for Q3 2016, filed 15 Nov 2016.